Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.18 USD | -1.20% | +5.47% | +80.77% |
Financials (USD)
Sales 2024 * | 197M | Sales 2025 * | 218M | Capitalization | 875M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -52M | EV / Sales 2024 * | 4.38 x |
Net cash position 2024 * | 11.13M | Net cash position 2025 * | 41.33M | EV / Sales 2025 * | 3.82 x |
P/E ratio 2024 * |
-16.2
x | P/E ratio 2025 * |
-16.9
x | Employees | 474 |
Yield 2024 * |
0.57% | Yield 2025 * |
-
| Free-Float | 95.74% |
Latest transcript on Silk Road Medical, Inc
1 day | -1.20% | ||
1 week | +5.47% | ||
Current month | +14.09% | ||
1 month | +27.32% | ||
3 months | +21.53% | ||
6 months | +160.94% | ||
Current year | +80.77% |
Managers | Title | Age | Since |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | Nov. 01 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 09-07-31 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 18-03-25 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 20-12-02 |
Jack Lasersohn
CHM | Chairman | 70 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 22.18 | -1.20% | 491,374 |
24-05-16 | 22.45 | +3.65% | 712,039 |
24-05-15 | 21.66 | +2.70% | 429,262 |
24-05-14 | 21.09 | +1.79% | 495,414 |
24-05-13 | 20.72 | -1.47% | 384,403 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.77% | 875M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- SILK Stock